EUVIMEDEUVIMED entdecken
Crossref

Outcomes of follow-up oral food challenges in young children on oral immunotherapy

Srushti Raja, Kara McNamara, Jaclyn Bjelac

Journal of Food Allergy · 01.07.2026 · 8 (1) · 51-54

DOI: 10.2500/jfa.2026.8.260005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Food Allergy, erschienen am 01.07.2026. Verfasst von Srushti Raja und 2 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oral immunotherapy (OIT) has been demonstrated to be safe in young children, including preschool age children. There are limited data with regard to long-term outcomes after achieving maintenance OIT (mOIT) for very young children.

Objective

Our study aimed to provide data on outcomes of oral food challenges (OFC) conducted in young children after time on mOIT and subsequent integration of specific food allergens into the daily diet.

Methods

The institutional review board approved chart review was conducted of 96 patients who began OIT at ages ≤5 years (average 23 months) who underwent OFCs after reaching mOIT. Demographics, length of mOIT, testing, cumulative OFC protein dose, recommendations after OFC, and any adverse reactions after OFC while freely consuming the index allergen were collected.

Results

Of 96 patients, 30 received multifood OIT. There were 123 OFCs in total: peanut (67), cashew (27), sesame (12), walnut (11), baked egg (2), milk (1), baked milk (1), wheat (2). OFCs were offered after a mean of 12.7 months on mOIT (range 4 to 47 months). The patients continued daily dosing until OFC. Children consumed variable protein amounts of index food during the OFC (2 g to 8.8 g). All OFCs were completed without reaction requiring treatment, and the patients were advised to consume the index food a minimum of twice weekly in large servings. At OFC follow-up (average 16 months after OFC), 89 of the 96 patients (93%) were documented to be free-eating. Several patients reported oral itching, but no patients discontinued index food consumption (although one patient was lost to follow-up).

Conclusion

OIT in very young children offers considerable protection beyond “bite-proof” dosing, which allows many patients to transition to free-eating, which demonstrated favorable long-term efficacy in this age group. More studies are needed to identify optimal dosing and laboratory markers that can be used to identify when OFC is appropriate while on mOIT.

Zitieren

APA

Raja, S., McNamara, K., & Bjelac, J. (2026). Outcomes of follow-up oral food challenges in young children on oral immunotherapy. Journal of Food Allergy, 8(1), 51-54. https://doi.org/10.2500/jfa.2026.8.260005

Vancouver

Raja S, McNamara K, Bjelac J. Outcomes of follow-up oral food challenges in young children on oral immunotherapy. Journal of Food Allergy. 2026;8(1):51-54. doi:10.2500/jfa.2026.8.260005

BibTeX
@article{Raja2026,
  author = {Raja, Srushti and McNamara, Kara and Bjelac, Jaclyn},
  title = {Outcomes of follow-up oral food challenges in young children on oral immunotherapy},
  journal = {Journal of Food Allergy},
  year = {2026},
  volume = {8},
  number = {1},
  pages = {51--54},
  doi = {10.2500/jfa.2026.8.260005}
}
Kostenlos starten →